10 Adverse events 5% in SUSTAIN 5 8,10 AEs occurring in 5% of participants treated with Ozempic in SUSTAIN 5 Incidence of severe hypoglycemia was 1.5% across all placebo-controlled trials 1 Incidence of severe hypoglycemia or blood glucose-confirmed hypoglycemia (% of patients) was 8,10 : 8.3% with Ozempic 0.5 mg + basal insulin MET 10.7% with Ozempic 1 mg + basal insulin MET 5.3% with placebo + basal insulin MET Patients receiving Ozempic in combination with an insulin secretagogue (eg, sulfonylurea) or insulin may have an increased risk of hypoglycemia, including severe hypoglycemia 1 ADA=American Diabetes Association
Cagrilintide is the more handling-sensitive of the two - never shake, and discard cloudy solution
Tout produit ayant des effets secondaires potentiellement ngatifs, au vu des maigres avantages possibles, je me passerai de ce produit l'avenir 15 personnes ont trouv ce commentaire utile Cet avis vous a t utile
Lker huden inifrn, inte bara p ytan: Medan vanliga hudkrmer bara nr de yttersta lagren, verkar Glox systemiskt
Your clinician may want to monitor more closely
